Moreover, ZYX overexpression prevented osteosarcoma cells from proliferating, migrating, and invading, whereas ZYX silencing showed the opposite effect, further supporting the idea that ZYX acts as a tumor suppressor in patients with osteosarcoma. This evidence concerns the gene ZYX and osteosarcoma.